[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:csf3r-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"CSF3R Gene",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07032727","Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations",[11],"Phase 2","RECRUITING","2026-08-26T02:15:38.131683Z","2026-05-05T02:43:28.209956Z"]